David P. Schenkein - Oct 19, 2022 Form 3 Insider Report for Prime Medicine, Inc. (PRME)

Role
Director
Signature
/s/ Carman Alenson attorney-in-fact
Stock symbol
PRME
Transactions as of
Oct 19, 2022
Transactions value $
$0
Form type
3
Date filed
10/19/2022, 08:09 PM
Previous filing
Jun 23, 2022
Next filing
Jan 19, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney